Bogduk N, Mercer S Biomechanics of the cervical spine. I: Normal kinematics. Clin Biomech (Bristol, Avon). 2000 Nov;15(9):633-48. Review.
Boselie TF, van Mameren H, de Bie RA, van Santbrink H Cervical spine kinematics after anterior cervical discectomy with or without implantation of a mobile cervical disc prosthesis; an RCT. BMC Musculoskelet Disord. 2015 Feb 21;16:34. doi: 10.1186/s12891-015-0479-4.
Boselie TFM, van Santbrink H, de Bie RA, van Mameren H Pilot Study of Sequence of Segmental Contributions in the Lower Cervical Spine During Active Extension and Flexion: Healthy Controls Versus Cervical Degenerative Disc Disease Patients. Spine (Phila Pa 1976). 2017 Jun 1;42(11):E642-E647. doi: 10.1097/BRS.0000000000001914.
Côté P, Cassidy JD, Yong-Hing K, Sibley J, Loewy J Apophysial joint degeneration, disc degeneration, and sagittal curve of the cervical spine. Can they be measured reliably on radiographs? Spine (Phila Pa 1976). 1997 Apr 15;22(8):859-64.
KELLGREN JH, LAWRENCE JS Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957 Dec;16(4):494-502.
Simpson AK, Biswas D, Emerson JW, Lawrence BD, Grauer JN Quantifying the effects of age, gender, degeneration, and adjacent level degeneration on cervical spine range of motion using multivariate analyses. Spine (Phila Pa 1976). 2008 Jan 15;33(2):183-6. doi: 10.1097/BRS.0b013e31816044e8.
Van Mameren H, Drukker J, Sanches H, Beursgens J Cervical spine motion in the sagittal plane (I) range of motion of actually performed movements, an X-ray cinematographic study. Eur J Morphol. 1990;28(1):47-68.
Vernon H, Mior S The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther. 1991 Sep;14(7):409-15. Erratum in: J Manipulative Physiol Ther 1992 Jan;15(1):followi.
Analysis of Cervical Motion During Flexion and Extension Cinematographic Recordings in Asymptomatic Elderly
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
